Maxkos Pharmaceuticals Private Limited
About Maxkos Pharmaceuticals Private Limited
Data last updated:
Maxkos Pharmaceuticals Private Limited is a private limited company based in Solapur, Maharashtra, India. It operates in the chemical products segment of the chemicals sector. It was incorporated on 24 April 2007 and has been in existence for over 19 years.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U24239PN2007PTC130031. Its GSTIN is 27AAFCM8281R1ZJ (Maharashtra).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹3.55 Lakh. It was formerly known as Maxkos Pharmaceuticals & Softwares Private Limited. It is led by directors Uma Kashinath Patil and Kashinath Dhondu Patil.
Its last annual general meeting (AGM) was held on 17 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 116 Industrial Estate Hotgi Road, Solapur, Maharashtra, India – 413003.
As per the financials filed for FY 2025, the company reported a revenue of ₹13.63 Lakh, a decline of 65% compared to the previous year. For the same year it recorded a net loss of ₹2.39 Lakh (net margin -17.5%) and EBITDA of -₹1.93 Lakh (EBITDA margin -14.2%). Revenue has declined at a compounded annual rate (CAGR) of 606% over three years and 25% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address116 Industrial Estate Hotgi Road, Solapur, Maharashtra, India – 413003
- IndustryChemicals, Chemical Products, Medicinal Chemical & Botanical Products, Pharmaceuticals
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Maxkos Pharmaceuticals Private Limited
The main business activity of Maxkos Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Maxkos Pharmaceuticals Private Limited FY 2025 filings available
Maxkos Pharmaceuticals Private Limited reported revenue of ₹13.63 Lakh (down 65% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Maxkos Pharmaceuticals Private Limited
Revenue has declined at a compounded annual rate (CAGR) of 25% over five years, including a 65% fall in the latest year. EBITDA fell 353% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Maxkos Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹1.93 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹2.39 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Maxkos Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -14.2% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -17.5% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Maxkos Pharmaceuticals are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Maxkos Pharmaceuticals Private Limited
Maxkos Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Ecostan Pharmaceuticals Private Limited | ₹13.72 Lakh (FY 2024) | •••• | •••• | 314.0% | •••• | Mumbai, Maharashtra, India |
| Inexios Pharmaceuticals Private Limited | ₹13.72 Lakh (FY 2025) | •••• | •••• | 23.0% | •••• | Bangalore, Karnataka, India |
| Barmed Drugs Pharmaceuticals Private Limited | ₹13.7 Lakh (FY 2024) | •••• | •••• | -6.0% | •••• | Silchar, Assam, India |
| Aryan Pharmaceuticals Pvt Ltd | ₹13.69 Lakh (FY 2022) | •••• | •••• | -59.0% | •••• | Mumbai, Maharashtra, India |
| Dr. CSW Pharmaceuticals Private Limited | ₹13.67 Lakh (FY 2023) | •••• | •••• | 36.0% | •••• | Akola, Maharashtra, India |
| Maxkos Pharmaceuticals Private Limited this company | ₹13.63 Lakh (FY 2025) | •••• | •••• | -65.0% | •••• | Solapur, Maharashtra, India |
| Ryokona Pharmaceuticals Private Limited | ₹13.59 Lakh (FY 2025) | •••• | •••• | -34.0% | •••• | Gorakhpur, Uttar Pradesh, India |
| Sangie Pharmaceuticals Private Limited | ₹13.57 Lakh (FY 2025) | •••• | •••• | -80.0% | •••• | Thane, Maharashtra, India |
| Miron Pharmaceuticals Private Limited | ₹13.5 Lakh (FY 2024) | •••• | •••• | 15.0% | •••• | Nellore, Andhra Pradesh, India |
| Nextone Pharmaceuticals Private Limited | ₹13.5 Lakh (FY 2024) | •••• | •••• | 65.0% | •••• | Lucknow, Uttar Pradesh, India |
| P.G.H Pharmaceuticals India Private Limited | ₹13.49 Lakh (FY 2025) | •••• | •••• | -16.0% | •••• | Mathura, Uttar Pradesh, India |
Peers are the five companies nearest above and the five nearest below Maxkos Pharmaceuticals by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Maxkos Pharmaceuticals Private Limited
Maxkos Pharmaceuticals Private Limited is audited by ANILGOVINDSHRIGONDEKAR for the financial year 2017.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| ANILGOVINDSHRIGONDEKAR | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Maxkos Pharmaceuticals Private Limited
Maxkos Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Uma Kashinath Patil | Director | 24 Apr 2007 | 19 Years 5 Months | Current |
| Kashinath Dhondu Patil | Director | 24 Apr 2007 | 19 Years 5 Months | Current |
Ownership and Shareholding of Maxkos Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Maxkos Pharmaceuticals Private Limited
Maxkos Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Maxkos Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Maxkos Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Maxkos Pharmaceuticals Private Limited
Maxkos Pharmaceuticals Private Limited has 2 board changes on record since 2007: 2 appointments. The latest: Kashinath Dhondu Patil was appointed as Director on 24 Apr 2007.
Credit Ratings, Litigation & Regulatory Alerts for Maxkos Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Maxkos Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Maxkos Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Maxkos Pharmaceuticals Private Limited
Maxkos Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAFCM8281R1ZJ | Maharashtra | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Maxkos Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Maxkos Pharmaceuticals Private Limited
Maxkos Pharmaceuticals is an active private limited company based in Solapur, Maharashtra, India. The company works in chemical products, within the chemicals industry. It was incorporated on 24 April 2007 (19+ years old) and is registered under CIN U24239PN2007PTC130031.
Maxkos Pharmaceuticals reported revenue of ₹13.63 Lakh for FY 2025 (down 65% YoY).
Maxkos Pharmaceuticals has 2 current directors:
- Uma Kashinath Patil - Director
- Kashinath Dhondu Patil - Director
Maxkos Pharmaceuticals reported a net loss of ₹2.39 Lakh (net margin -17.5%) and EBITDA of -₹1.93 Lakh (EBITDA margin -14.2%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Maxkos Pharmaceuticals is 606% over three years and -25% over five years. In the latest year (FY 2025) revenue fell 65%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Maxkos Pharmaceuticals is 27AAFCM8281R1ZJ, registered in Maharashtra.
The CIN (Corporate Identification Number) of Maxkos Pharmaceuticals is U24239PN2007PTC130031. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Maxkos Pharmaceuticals was incorporated on 24 April 2007, making it 19+ years old. It is registered with the Registrar of Companies, Pune.
The peers of Maxkos Pharmaceuticals by revenue are Ecostan Pharmaceuticals Private Limited, Inexios Pharmaceuticals Private Limited, Barmed Drugs Pharmaceuticals Private Limited, Aryan Pharmaceuticals Pvt Ltd, Dr. CSW Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).
Kashinath Dhondu Patil was appointed as Director on 24 Apr 2007. Uma Kashinath Patil was appointed as Director on 24 Apr 2007.
The registered office of Maxkos Pharmaceuticals is at 116 Industrial Estate Hotgi Road, Solapur, Maharashtra, India – 413003.